ARCHIVES

Phase III Cyramza Trial Meets OS Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Racial Differences In Survival Increase According To Stage

August 31, 2007

Study Links Breast, Pancreatic Cancer Risks to Lynch Syndrome

February 24, 2012

Possible Breach of Patient Confidentially By Calif. Physician; NCI

May 6, 1994

Clearinghouse Agrees: Three Dyes, Hair Color Agent Are Carcinogens; Risk To Humans – Brown

May 5, 1978

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

November 20, 1992

Human Genome Consortium Completes “Working Draft”.

June 30, 2000